Carolyn Sufrin1,2,3, Lauren Sutherland4, Lauren Beal1,2, Mishka Terplan5, Carl Latkin3, Jennifer G Clarke6. 1. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Johns Hopkins Bayview Hospital, Baltimore, MD, USA. 3. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 4. Johns Hopkins University School of Medicine, Baltimore, MD, USA. 5. Friends Research Institute, Baltimore, MD, USA. 6. Rhode Island Department of Corrections, Rhode Island Department of Corrections, Cranston, RI, USA.
Abstract
BACKGROUND AND AIMS: The established standard care in pregnancy is medication for opioid use disorder (MOUD); however, many institutions of incarceration do not have MOUD available. We aimed to describe the number of incarcerated pregnant women with opioid use disorder (OUD) in the United States and jails' and prisons' MOUD in pregnancy policies. DESIGN: Epidemiological surveillance study of 6 months of outcomes of pregnant, incarcerated women with OUD and cross-sectional survey of institutional policies. SETTING: United States. PARTICIPANTS: Twenty-two state prison systems and six county jails. MEASUREMENTS: The number of pregnant women with OUD admitted and treated with methadone, buprenorphine or withdrawal; policies on provision of MOUD and withdrawal in pregnancy. FINDINGS: Twenty-six per cent of pregnant women admitted to prisons and 14% to jails had OUD. One-third were managed through withdrawal. The majority who were prescribed MOUD were on methadone (78%, prisons; 81%, jails), not buprenorphine. While most sites (n = 18 prisons, n = four jails) continued pre-incarceration MOUD in pregnancy, very few initiated in custody (n = four prisons; n = two jails). Two-thirds of prisons and three-quarters of jails providing MOUD in pregnancy discontinued it postpartum. CONCLUSIONS: In this sample of US prisons and jails, one-third required pregnant women with opioid use disorder to go through withdrawal, contrary to medical guidelines. More women were prescribed methadone than buprenorphine, despite the fewer regulatory barriers on prescribing buprenorphine. Most sites stopped medication for opioid use disorder postpartum, signaling prioritization of the fetus, not the mother. Pregnant incarcerated women with opioid use disorder in the United States frequently appear to be denied essential medications and receive substandard medical care.
BACKGROUND AND AIMS: The established standard care in pregnancy is medication for opioid use disorder (MOUD); however, many institutions of incarceration do not have MOUD available. We aimed to describe the number of incarcerated pregnant women with opioid use disorder (OUD) in the United States and jails' and prisons' MOUD in pregnancy policies. DESIGN: Epidemiological surveillance study of 6 months of outcomes of pregnant, incarcerated women with OUD and cross-sectional survey of institutional policies. SETTING: United States. PARTICIPANTS: Twenty-two state prison systems and six county jails. MEASUREMENTS: The number of pregnant women with OUD admitted and treated with methadone, buprenorphine or withdrawal; policies on provision of MOUD and withdrawal in pregnancy. FINDINGS: Twenty-six per cent of pregnant women admitted to prisons and 14% to jails had OUD. One-third were managed through withdrawal. The majority who were prescribed MOUD were on methadone (78%, prisons; 81%, jails), not buprenorphine. While most sites (n = 18 prisons, n = four jails) continued pre-incarceration MOUD in pregnancy, very few initiated in custody (n = four prisons; n = two jails). Two-thirds of prisons and three-quarters of jails providing MOUD in pregnancy discontinued it postpartum. CONCLUSIONS: In this sample of US prisons and jails, one-third required pregnant women with opioid use disorder to go through withdrawal, contrary to medical guidelines. More women were prescribed methadone than buprenorphine, despite the fewer regulatory barriers on prescribing buprenorphine. Most sites stopped medication for opioid use disorder postpartum, signaling prioritization of the fetus, not the mother. Pregnant incarcerated women with opioid use disorder in the United States frequently appear to be denied essential medications and receive substandard medical care.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Carolyn Sufrin; Lauren Beal; Jennifer Clarke; Rachel Jones; William D Mosher Journal: Am J Public Health Date: 2019-03-21 Impact factor: 9.308
Authors: Mishka Terplan; Hollis J Laird; Dennis J Hand; Tricia E Wright; Ashish Premkumar; Caitlin E Martin; Marjorie C Meyer; Hendrée E Jones; Elizabeth E Krans Journal: Obstet Gynecol Date: 2018-05 Impact factor: 7.661
Authors: Davida M Schiff; Timothy Nielsen; Mishka Terplan; Malena Hood; Dana Bernson; Hafsatou Diop; Monica Bharel; Timothy E Wilens; Marc LaRochelle; Alexander Y Walley; Thomas Land Journal: Obstet Gynecol Date: 2018-08 Impact factor: 7.661
Authors: Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan Journal: MMWR Morb Mortal Wkly Rep Date: 2018-08-10 Impact factor: 17.586
Authors: Andrea K Knittel; Rita A Swartzwelder; Samantha Zarnick; Tamy Harumy Moraes Tsujimoto; Timelie Horne; Feng-Chang Lin; James Edwards; Elton Amos; James Alexander; John Thorp; Hendree E Jones Journal: Drug Alcohol Depend Date: 2022-01-15 Impact factor: 4.492
Authors: Cynthia A Golembeski; Carolyn B Sufrin; Brie Williams; Precious S Bedell; Sherry A Glied; Ingrid A Binswanger; Donna Hylton; Tyler N A Winkelman; Jaimie P Meyer Journal: Womens Health Issues Date: 2020-07-29
Authors: Davida M Schiff; Timothy C Nielsen; Bettina B Hoeppner; Mishka Terplan; Scott E Hadland; Dana Bernson; Shelly F Greenfield; Judith Bernstein; Monica Bharel; Julia Reddy; Elsie M Taveras; John F Kelly; Timothy E Wilens Journal: Am J Obstet Gynecol Date: 2021-04-15 Impact factor: 10.693
Authors: Tyler N A Winkelman; Becky R Ford; Rebecca J Shlafer; Anna McWilliams; Lindsay K Admon; Stephen W Patrick Journal: PLoS Med Date: 2020-05-18 Impact factor: 11.069
Authors: Carolyn Sufrin; Camille T Kramer; Mishka Terplan; Kevin Fiscella; Sarah Olson; Kristin Voegtline; Carl Latkin Journal: JAMA Netw Open Date: 2022-01-04